Evidence map›Paper›PMID 16393662›Full record

ArticleEnvironmental health perspectives2006

Evidence of spatially extensive resistance to PCBs in an anadromous fish of the Hudson River.

Zhanpeng Yuan, Simon Courtenay, R Christopher Chambers, Isaac Wirgin

Open access · diamondAbstract read
In one paragraph

Article in Environmental health perspectives, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
1.4field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 39 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Tissue Distribution and Immunomodulation in Channel Catfish (International journal of environmental research and public health · 2020
    Article
  4. Article
  5. Evolutionary toxicology in an omics world.Evolutionary applications · 2017
    Article
  6. Article
  7. A multibiomarker approach on the Atlantic tomcod (Microgadus tomcod) in the St. Lawrence Estuary.Environmental science and pollution research international · 2013
    Article
  8. Genetic architecture of susceptibility to PCB126-induced developmental cardiotoxicity in zebrafish.Toxicological sciences : an official journal of the Society of Toxicology · 2011
    Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 2 countries.

Zhanpeng YuanDepartment of Environmental Medicine, New York University School of Medicine, Tuxedo, New York 10987, USA.
Simon Courtenay
R Christopher Chambers
Isaac Wirgin
New York University · USNational Oceanic and Atmospheric Administration · USUniversity of New Brunswick · CA

Funding

RESEARCH IN ENVIRONMENTAL HEALTH SCIENCES (CENTER GRANT)P30ES000260 · NIEHS · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI GOLDBERG, JUDITH D. · 1985 to 2020
$26.1M
Water/sediment &model &criteria for arsenic &chromeP42ES010344 · NIEHS · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI COSTA, MAX · 2000 to 2010
$15.0M
NIEHS NIH HHS ES00260NIEHS NIH HHS ES10344NIEHS NIH HHS P30 ES000260NIEHS NIH HHS P42 ES010344
6 · The paper itself

Abstract

Populations of organisms that are chronically exposed to high levels of chemical contaminants may not suffer the same sublethal or lethal effects as naive populations, a phenomenon called resistance. Atlantic tomcod (Microgadus tomcod) from the Hudson River, New York, are exposed to high concentrations of polycyclic aromatic hydrocarbons (PAHs) and bioaccumulate polychlorinated biphenyls (PCBs), polychlorinated dibenzo-p-dioxins (PCDDs), and polychlorinated dibenzofurans (PCDFs). They have developed resistance to PCBs and PCDDs but not to PAHs. Resistance is largely heritable and manifests at early-life-stage toxic end points and in inducibility of cytochrome P4501A (CYP1A) mRNA expression. Because CYP1A induction is activated by the aryl hydrocarbon receptor (AHR) pathway, as are most toxic responses to these compounds, we sought to determine the geographic extent of resistance to CYP1A mRNA induction by PCBs in the Hudson River tomcod population. Samples of young-of-the-year tomcod were collected from seven locales in the Hudson River, extending from the Battery at river mile 1 (RM 1) to RM 90, and from the Miramichi River, New Brunswick, Canada. Laboratory-reared offspring of tomcod adults from Newark Bay, in the western portion of the Hudson River estuary, were also used in this study. Fish were partially depurated in clean water and intraperitoneally injected with 10 ppm coplanar PCB-77, 10 ppm benzo[a]pyrene (BaP), or corn oil vehicle, and levels of CYP1A mRNA were determined. CYP1A was significantly inducible by treatment with BaP in tomcod from the Miramichi River, from laboratory-spawned offspring of Newark Bay origin, and from all Hudson River sites spanning 90 miles of river. In contrast, only tomcod from the Miramichi River displayed significantly induced CYP1A mRNA expression when treated with PCB-77. Our results suggest that the population of tomcod from throughout the Hudson River estuary has developed resistance to CYP1A inducibility and probably other toxicities mediated by the AHR pathway. Tomcod from the Hudson River may represent the most geographically expansive population of vertebrates with resistance to chemical pollutants that has been characterized.

Indexed as

Drug ResistanceAnimalsBenzo(a)pyreneCytochrome P-450 CYP1A1GadiformesGene Expression Regulation, EnzymologicLiverPolychlorinated BiphenylsRiversRNA, MessengerWater Pollutants, ChemicalBenzo(a)pyreneCytochrome P-450 CYP1A1Polychlorinated BiphenylsRNA, MessengerWater Pollutants, Chemical

Identifiers

PMID16393662
PMCPMC1332660
OpenAlexW1971225539

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.